The conversation delves into the surprising surge in ketamine clinics and its off-label use for treating depression, particularly in cases resistant to traditional therapies. John highlights the significant response rates observed in patients, while contrasting the hype surrounding ketamine with the more complex field of regenerative medicine, which lacks similar visibility despite its long-standing applications. The importance of proper training and patient screening in administering ketamine is also emphasized.
